chlorine dioxide may be effective for infected diabetic foot ulcers

1
Inpharma 1628 - 8 Mar 2008 A Microcyn Technology platform, containing chlorine dioxide, * may be effective for mildly infected diabetic foot ulcers. In a phase II, open-label study, 66 patients were randomised to receive Microcyn alone, Microcyn in combination with levofloxacin, or levofloxacin alone for 10 days; at day 10, the clinical success rates for the three treatment groups were 75%, 64% and 57%, respectively. At day 24, the respective clinical success rates were 75%, 72% and 52%. * Oculus Innovative Sciences; phase II in the US for diabetic foot ulcer infections, preregistration in China Oculus Innovative Sciences. Oculus Innovative Sciences Announces Positive Top-Line Phase II Data with Microcyn (Rm) Technology in Mildly Infected Diabetic Foot Ulcers. Media Release : 28 Feb 2008. Available from: URL: http://www.oculusis.com 809085732 1 Inpharma 8 Mar 2008 No. 1628 1173-8324/10/1628-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Post on 12-Dec-2016

214 views

Category:

Documents


1 download

TRANSCRIPT

Inpharma 1628 - 8 Mar 2008

■ A Microcyn Technology platform, containingchlorine dioxide,* may be effective for mildly infecteddiabetic foot ulcers. In a phase II, open-label study,66 patients were randomised to receive Microcynalone, Microcyn in combination with levofloxacin, orlevofloxacin alone for 10 days; at day 10, the clinicalsuccess rates for the three treatment groups were75%, 64% and 57%, respectively. At day 24, therespective clinical success rates were 75%, 72% and52%.* Oculus Innovative Sciences; phase II in the US for diabetic footulcer infections, preregistration in China

Oculus Innovative Sciences. Oculus Innovative Sciences Announces PositiveTop-Line Phase II Data with Microcyn (Rm) Technology in Mildly InfectedDiabetic Foot Ulcers. Media Release : 28 Feb 2008. Available from: URL:http://www.oculusis.com 809085732

1

Inpharma 8 Mar 2008 No. 16281173-8324/10/1628-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved